Rockwell Medical (Nasdaq: RMTI) 26.3% LOWER; summarized findings from its completed Phase IIb clinical study. The study evaluated Soluble Ferric Pyrophosphate, the Company’s proprietary investigational product for continuous iron maintenance therapy in chronic hemodialysis patients. Click here for the full report.

CKE Restaurants, Inc. (NYSE: CKR) 25.9% HIGHER; CKE and Thomas H. Lee Partners today announced that they have entered into a definitive merger agreement under which THL will acquire CKE for approximately $928 million, including the assumption of approximately $309 million of net debt. Under the terms of the agreement, CKE stockholders will receive $11.05 in cash